Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Goldstein

Showing results (151-160 of 663) with videos related to

Pageof 67
Sort By:
Antimicrobial Agents and Chemotherapy|July 8, 2020
<i>In Vitro</i> Activity of Tedizolid Compared to Linezolid and Five Other Antimicrobial Agents against 332 Anaerobic Isolates, Including Bacteroides fragilis Group, <i>Prevotella</i>, <i>Porphyromonas</i>, and <i>Veillonella</i> SpeciesEllie J C Goldstein, C Vreni Merriam, Diane M Citron
Journal of the American Academy of Child Psychiatry|May 1, 1985
Is juvenile delinquency related to an abnormal EEG? A study of EEG abnormalities in juvenile delinquents and adolescent psychiatric inpatientsL K Hsu, K Wisner, E T Richey, et al.
American Journal of Human Biology : the Official Journal of the Human Biology Council|May 31, 2017
Basal metabolic rate and dietary seasonality among Tibetan nomadsCynthia M Beall, Jeye Henry, Carol Worthman, et al.
Frontiers in Medicine|June 6, 2018
Strain-Specificity and Disease-Specificity of Probiotic Efficacy: A Systematic Review and Meta-AnalysisLynne V McFarland, Charlesnika T Evans, Ellie J C Goldstein
Expert Opinion on Investigational Drugs|February 13, 2019
Investigational drug therapies currently in early-stage clinical development for the treatment of clostridioides (clostridium) difficile infectionMai-Chi N Tran, Ravina Kullar, Ellie J C Goldstein
Expert Review of Anti-Infective Therapy|August 12, 2014
Clostridium difficile: improving the prevention paradigm in healthcare settingsAngela Vassallo, Mai-Chi N Tran, Ellie J C Goldstein
Antimicrobial Agents and Chemotherapy|November 20, 2013
Comparative in vitro activities of SMT19969, a new antimicrobial agent, against 162 strains from 35 less frequently recovered intestinal Clostridium species: implications for Clostridium difficile recurrenceEllie J C Goldstein, Diane M Citron, Kerin L Tyrrell
Journal of Experimental Pharmacology|October 29, 2020
Investigational Treatment Agents for Recurrent <i>Clostridioides difficile</i> Infection (rCDI)Ravina Kullar, Mai-Chi N Tran, Ellie J C Goldstein
Diagnostic Microbiology and Infectious Disease|June 29, 2014
Comparative in vitro activities of dalbavancin and seven comparator agents against 41 Staphylococcus species cultured from osteomyelitis infections and 18 VISA and hVISA strainsDiane M Citron, Kerin L Tyrrell, Ellie J C Goldstein
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 30, 2015
Lactobacillus species: taxonomic complexity and controversial susceptibilitiesEllie J C Goldstein, Kerin L Tyrrell, Diane M Citron
Pageof 67

Showing results (151-160 of 663) with videos related to

Sort By:
Pageof 67
Antimicrobial Agents and Chemotherapy|July 8, 2020
<i>In Vitro</i> Activity of Tedizolid Compared to Linezolid and Five Other Antimicrobial Agents against 332 Anaerobic Isolates, Including Bacteroides fragilis Group, <i>Prevotella</i>, <i>Porphyromonas</i>, and <i>Veillonella</i> SpeciesEllie J C Goldstein, C Vreni Merriam, Diane M Citron
Journal of the American Academy of Child Psychiatry|May 1, 1985
Is juvenile delinquency related to an abnormal EEG? A study of EEG abnormalities in juvenile delinquents and adolescent psychiatric inpatientsL K Hsu, K Wisner, E T Richey, et al.
American Journal of Human Biology : the Official Journal of the Human Biology Council|May 31, 2017
Basal metabolic rate and dietary seasonality among Tibetan nomadsCynthia M Beall, Jeye Henry, Carol Worthman, et al.
Frontiers in Medicine|June 6, 2018
Strain-Specificity and Disease-Specificity of Probiotic Efficacy: A Systematic Review and Meta-AnalysisLynne V McFarland, Charlesnika T Evans, Ellie J C Goldstein
Expert Opinion on Investigational Drugs|February 13, 2019
Investigational drug therapies currently in early-stage clinical development for the treatment of clostridioides (clostridium) difficile infectionMai-Chi N Tran, Ravina Kullar, Ellie J C Goldstein
Expert Review of Anti-Infective Therapy|August 12, 2014
Clostridium difficile: improving the prevention paradigm in healthcare settingsAngela Vassallo, Mai-Chi N Tran, Ellie J C Goldstein
Antimicrobial Agents and Chemotherapy|November 20, 2013
Comparative in vitro activities of SMT19969, a new antimicrobial agent, against 162 strains from 35 less frequently recovered intestinal Clostridium species: implications for Clostridium difficile recurrenceEllie J C Goldstein, Diane M Citron, Kerin L Tyrrell
Journal of Experimental Pharmacology|October 29, 2020
Investigational Treatment Agents for Recurrent <i>Clostridioides difficile</i> Infection (rCDI)Ravina Kullar, Mai-Chi N Tran, Ellie J C Goldstein
Diagnostic Microbiology and Infectious Disease|June 29, 2014
Comparative in vitro activities of dalbavancin and seven comparator agents against 41 Staphylococcus species cultured from osteomyelitis infections and 18 VISA and hVISA strainsDiane M Citron, Kerin L Tyrrell, Ellie J C Goldstein
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 30, 2015
Lactobacillus species: taxonomic complexity and controversial susceptibilitiesEllie J C Goldstein, Kerin L Tyrrell, Diane M Citron
Pageof 67